Latest Stories

Don’t miss our hot and upcoming stories
CytoReason Raises $80M from OurCrowd, NVIDIA, Pfizer & Thermo Fisher to Advance AI Disease Models and Launch U.S. Hub

New funding will scale CytoReason’s AI platform, expand disease models, and support a new office…

ByByAnuja SinghJul 17, 2024
GSK Partners with Ochre Bio in $37.5 Million AI-Driven Liver Disease Collaboration

London, UK – June 12 2024 GSK has entered into a $37.5 million strategic partnership…

ByByAnuja SinghJun 12, 2024
Sanofi, Formation Bio, and OpenAI Forge Strategic Alliance to Revolutionize Pharma with AI

Paris, New York, N.Y., and San Francisco, CA — May 21, 2024 Sanofi, Formation Bio,…

ByByAnuja SinghMay 21, 2024
Recursion Unveils BioHive-2: The World’s Largest AI Supercomputer in Pharma

Salt Lake City – May 13, 2024 Recursion Pharmaceuticals, a leading clinical-stage TechBio company, has…

ByByAnuja SinghMay 13, 2024
Scroll to Top